Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afterload Reduction Therapy for Late Anthracycline Cardiotoxicity
NCT00003070Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Sep 2000
- Primary completion
- Jul 2003
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of enalapril in Cardiotoxicity, sponsored by Children's Oncology Group. Started Sep 2000; status: completed.
02
Drugs
enalapril
03
Conditions
Cardiotoxicity
Beyond the preview
Go deeper on NCT00003070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003070.